OVERVIEW

Researchers are studying mechanisms that govern metabolic and cardiovascular homeostasis.

These processes often become defective in obesity resulting in the development of chronic diseases such as type 2 diabetes and cardiovascular disease. In vitro and in vivo systems are used together with a range of techniques involving molecular and cellular biology combined with biochemistry and ‘omics’ approaches to define molecular mechanisms that contribute to cardiometabolic health.

Key Researchers
 
Emma Hamilton-Williams
John Prins
Jon Whitehead
Michael McGuckin
Ranjeny Thomas
Show More ...
Key Aims
 
  • To identify novel strategies to reduce cardiometabolic disease.
METABOLOMICS RESEARCH PROGRAMS
Click a program below to learn more
 
Addiction
Diabetes (1&2)
Obesity